Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Incidence of multiple sclerosis in Northern Lisbon, Portugal: 1998¿2007.
Multiple sclerosis: Does aggressive MS warrant aggressive treatment?
Delayed onset adenosine deaminase deficiency associated with acute disseminated encephalomyelitis.
Quantitative assessment of multiple sclerosis using inertial sensors and the TUG test.
Neurofilament light and heavy subunits compared as therapeutic biomarkers in multiple sclerosis.
Sleep Disorders and Multiple Sclerosis: A Clinical and Polysomnography Study.
A qualitative exploration of the impact of a 12-week group exercise class for those moderately affected with multiple sclerosis.
Mesenchymal stem cells expressing vasoactive intestinal peptide ameliorate symptoms in a model of chronic multiple sclerosis.
Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients.
Ocrelizumab in multiple sclerosis: risks and benefits.
[Pharmacological properties and clinical efficacy of fingolimod hydrochloride (Imusera®/Gilenya®) for the treatment of multiple sclerosis].
Comment on the letter by Messori et al. (European Journal of Neurology 2013; 20: e131).
Two discreet subsets of CD8 T cells modulate PLP(91-110) induced experimental autoimmune encephalomyelitis in HLA-DR3 transgenic mice.
[Cognitive impairment in demyelinating disease].
Progressive multiple sclerosis: The treatment gap.
Biochemical Markers of Autoimmune Diseases of the Nervous System.
Recommendations for the clinical use of motor evoked potentials in multiple sclerosis.
A randomized placebo-controlled trial of idebenone in Leber's hereditary optic neuropathy.
Genome-wide association study of multiple sclerosis confirms a novel locus at 5p13.1.
Comparative efficacy of fingolimod vs natalizumab: A French multicenter observational study.
Natalizumab exerts direct signaling capacity and supports a pro-inflammatory phenotype in some patients with multiple sclerosis.
Chronic inflammatory demyelinating polyneuropathy following malignant melanoma.
Influence of pregnancy on neuromyelitis optica spectrum disorder.
Successful desensitization to natalizumab in a skin test--positive patient: a case report.
Review of MR elastography applications and recent developments.

Pages